PULSE BIOSCIENCES, INC. (PLSE)
Data as of , from SEC Form 4 filings.
Net insider buying (90d)Watch PLSE
See up to 3 months of PLSE. The 7-day demo opens the 1M and 3M ranges and puts PLSE on your watchlist.
Start 7-day demoLatest PLSE insider trades
About PULSE BIOSCIENCES, INC. (PLSE)
PULSE BIOSCIENCES, INC. files with the SEC under CIK 0001625101 and is classified as surgical and medical instruments and apparatus. We track it alongside the rest of the Health Care sector.
PLSE Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 2 | 2,025 | $100K |
| Grant or award | 3 | 1,200,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
PLSE insider transactions (Form 4)
9232 Form 4 filings on record, the earliest from Dec 14, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Liane Rae Teplitsky - Officer | Open-market purchase | Common Stock | 1,024 footnote F2 | $48.80 footnote F3 | $50K | |
| Liane Rae Teplitsky - Officer | Open-market purchase | Common Stock | 1,001 footnote F2 | $49.95 footnote F4 | $50K | |
| ||||||
| Liane Rae Teplitsky - Officer | Grant or award | Restricted Stock Units | 200,000 | $0.00 | - | |
| Liane Rae Teplitsky - Officer | Grant or award | Stock Option (right to buy) | 700,000 | $0.00 | - | |
| Jon Skinner - Officer | Grant or award | Stock Option (right to buy) | 300,000 | $0.00 | - | |
| Mahkam Zanganeh - Director | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| Mahkam Zanganeh - Director | Grant or award | Stock Option (right to buy) | 14,504 | $0.00 | - | |
| Den Broek Richard van - Director | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| Den Broek Richard van - Director | Grant or award | Stock Option (right to buy) | 8,423 | $0.00 | - | |
 Robert W. Duggan - Director | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| Robert W. Duggan - Director | Grant or award | Stock Option (right to buy) | 12,495 | $0.00 | - | |
| Manmeet Singh Soni - Director | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| Maria Sainz - Director | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| Maria Sainz - Director | Grant or award | Stock Option (right to buy) | 3,793 | $0.00 | - | |
| Robert W. Duggan - Director | Open-market purchase | Common Stock | 660,233 | $19.69 | $13.00M | |
| Paul A. Laviolette - Officer | Open-market purchase | Common Stock | 15,000 | $19.69 | $295K | |
| Paul A. Laviolette - Officer | Open-market purchase | Common Stock | 15,000 | $19.69 footnote F2 | $295K | |
| ||||||
| Robert W. Duggan - Director | Open-market purchase | Common Stock | 660,233 | $19.69 footnote F2 | $13.00M | |
| ||||||
| Darrin Uecker - Officer | Grant or award | Restricted Stock Units | 100,000 | $0.00 | - | |
| Kevin Patrick Danahy - Officer | Option exercise | Common Stock | 5,000 | $1.53 | $8K | |
| Kevin Patrick Danahy - Officer | Open-market sale | Common Stock | 5,000 | $23.64 footnote F2 | $118K | |
| Kevin Patrick Danahy - Officer | Option exercise | Stock Option (right to buy) | 5,000 | $0.00 | - | |
| ||||||
| Kevin Patrick Danahy - Officer | Option exercise | Common Stock | 20,000 | $1.53 | $31K | |
| Kevin Patrick Danahy - Officer | Open-market sale | Common Stock | 20,000 | $23.37 footnote F2 | $467K | |
| Kevin Patrick Danahy - Officer | Option exercise | Common Stock | 20,000 | $1.53 | $31K | |
| Kevin Patrick Danahy - Officer | Open-market sale | Common Stock | 20,000 | $23.53 footnote F3 | $471K | |
| Kevin Patrick Danahy - Officer | Option exercise | Common Stock | 20,000 | $1.53 | $31K | |
| Kevin Patrick Danahy - Officer | Open-market sale | Common Stock | 20,000 | $23.63 footnote F4 | $473K | |
| Kevin Patrick Danahy - Officer | Option exercise | Stock Option (right to buy) | 20,000 | $0.00 | - | |
| Kevin Patrick Danahy - Officer | Option exercise | Stock Option (right to buy) | 20,000 | $0.00 | - | |
| Kevin Patrick Danahy - Officer | Option exercise | Stock Option (right to buy) | 20,000 | $0.00 | - | |
| ||||||
| Kevin Patrick Danahy - Officer | Option exercise | Common Stock | 20,000 | $1.53 | $31K | |
| Kevin Patrick Danahy - Officer | Open-market sale | Common Stock | 20,000 | $21.45 footnote F2 | $429K | |
| Kevin Patrick Danahy - Officer | Option exercise | Common Stock | 20,000 | $1.53 | $31K | |
| Kevin Patrick Danahy - Officer | Open-market sale | Common Stock | 20,000 | $23.52 footnote F3 | $470K | |
| Kevin Patrick Danahy - Officer | Option exercise | Common Stock | 20,000 | $1.53 | $31K | |
| Kevin Patrick Danahy - Officer | Open-market sale | Common Stock | 20,000 | $25.20 footnote F4 | $504K | |
| Kevin Patrick Danahy - Officer | Option exercise | Stock Option (right to buy) | 20,000 | $0.00 | - | |
| Kevin Patrick Danahy - Officer | Option exercise | Stock Option (right to buy) | 20,000 | $0.00 | - | |
| Kevin Patrick Danahy - Officer | Option exercise | Stock Option (right to buy) | 20,000 | $0.00 | - | |
| ||||||
| Maria Sainz - Director | Grant or award | Stock Option (right to buy) | 50,000 | $0.00 | - | |
| Maria Sainz - Director | Grant or award | Stock Option (right to buy) | 3,104 | $0.00 | - | |
| Kevin Patrick Danahy - Officer | Option exercise | Common Stock | 4,600 | $1.53 | $7K | |
| Kevin Patrick Danahy - Officer | Open-market sale | Common Stock | 4,600 | $18.53 footnote F2 | $85K | |
| Kevin Patrick Danahy - Officer | Option exercise | Stock Option (right to buy) | 4,600 | $0.00 | - | |
| ||||||
| Kevin Patrick Danahy - Officer | Option exercise | Common Stock | 20,000 | $1.53 | $31K | |
| Kevin Patrick Danahy - Officer | Open-market sale | Common Stock | 20,000 | $18.49 | $370K | |
| Kevin Patrick Danahy - Officer | Option exercise | Common Stock | 400 | $1.53 | $612 | |
| Kevin Patrick Danahy - Officer | Open-market sale | Common Stock | 400 | $18.48 | $7K | |
| Kevin Patrick Danahy - Officer | Option exercise | Stock Option (right to buy) | 20,000 | $0.00 | - | |
| Kevin Patrick Danahy - Officer | Option exercise | Stock Option (right to buy) | 400 | $0.00 | - | |
| Darrin Uecker - Officer | Option exercise | Common Stock | 25,000 | $4.00 | $100K | |
| Darrin Uecker - Officer | Open-market sale | Common Stock | 25,000 | $16.28 | $407K | |
| Darrin Uecker - Officer | Option exercise | Common Stock | 20,000 | $4.00 | $80K | |
| Darrin Uecker - Officer | Open-market sale | Common Stock | 20,000 | $16.21 | $324K | |
| Darrin Uecker - Officer | Option exercise | Common Stock | 61,534 | $4.00 | $246K | |
| Darrin Uecker - Officer | Option exercise | Common Stock | 100,000 | $4.00 | $400K | |
| Darrin Uecker - Officer | Option exercise | Stock Option (right to buy) | 25,000 | $0.00 | - | |
| Darrin Uecker - Officer | Option exercise | Stock Option (right to buy) | 20,000 | $0.00 | - | |
| Darrin Uecker - Officer | Option exercise | Stock Option (right to buy) | 61,534 | $0.00 | - | |
| Darrin Uecker - Officer | Option exercise | Stock Option (right to buy) | 100,000 | $0.00 | - | |
| Darrin Uecker - Officer | Option exercise | Common Stock | 25,000 | $4.00 | $100K | |
| Darrin Uecker - Officer | Open-market sale | Common Stock | 25,000 | $14.78 | $370K | |
| Darrin Uecker - Officer | Option exercise | Common Stock | 25,000 | $4.00 | $100K | |
| Darrin Uecker - Officer | Open-market sale | Common Stock | 25,000 | $14.32 | $358K | |
| Darrin Uecker - Officer | Option exercise | Common Stock | 25,000 | $4.00 | $100K | |
| Darrin Uecker - Officer | Open-market sale | Common Stock | 25,000 | $15.77 | $394K | |
| Darrin Uecker - Officer | Option exercise | Stock Option (right to buy) | 25,000 | $0.00 | - | |
| Darrin Uecker - Officer | Option exercise | Stock Option (right to buy) | 25,000 | $0.00 | - | |
| Darrin Uecker - Officer | Option exercise | Stock Option (right to buy) | 25,000 | $0.00 | - | |
| Robert W. Duggan - Director | Open-market purchase | Common Stock | 34,659 | $14.66 | $508K | |
| Robert W. Duggan - Director | Open-market purchase | Common Stock | 12,800 | $14.77 | $189K | |
| Robert W. Duggan - Director | Open-market purchase | Common Stock | 145,140 | $14.41 | $2.09M | |
| Manmeet Singh Soni - Director | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| Mahkam Zanganeh - Director | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| Mahkam Zanganeh - Director | Grant or award | Stock Option (right to buy) | 24,134 | $0.00 | - | |
| Den Broek Richard van - Director | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| Robert W. Duggan - Director | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| Robert W. Duggan - Director | Grant or award | Stock Option (right to buy) | 20,792 | $0.00 | - | |
| Steven Weber - Officer | Grant or award | Stock Option (right to buy) | 55,000 | $0.00 | - | |
| Darrin Uecker - Officer | Open-market sale | Common Stock | 15,000 | $16.40 | $246K | |
| Darrin Uecker - Officer | Open-market sale | Common Stock | 15,000 | $15.98 | $240K | |
| Burke Thomas Barrett | Open-market sale | Common Stock | 50,000 | $17.42 | $871K | |
| Robert W. Duggan | Other | Common Stock | 5,187,824 | $11.00 | $57.07M | |
| Robert W. Duggan | Other | Common Stock | 69,020 | $11.00 | $759K | |
| Robert W. Duggan | Other | Common Stock | 49,312 | $11.00 | $542K | |
| Robert W. Duggan | Other | Warrants (right to buy) | 2,593,912 | - | - | |
| Robert W. Duggan | Other | Warrants (right to buy) | 2,593,912 | - | - | |
| Robert W. Duggan | Other | Warrants (right to buy) | 34,510 | - | - | |
| Robert W. Duggan | Other | Warrants (right to buy) | 34,510 | - | - | |
| Robert W. Duggan | Other | Warrants (right to buy) | 24,656 | - | - | |
| Robert W. Duggan | Other | Warrants (right to buy) | 24,656 | - | - | |
Item 8.01, 9.01
Item 1.01, 1.02, 9.01
Item 8.01, 9.01
Item 1.01, 9.01
PLSE insider trading FAQ
What is the latest insider trade for PLSE?
PULSE BIOSCIENCES, INC. (PLSE) had 3 insider filings in the last 90 days, with the most recent on 2026-09-02. The full record for PLSE runs to 32 Form 4 filings, the earliest from 2024-12-14. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying PLSE stock?
2 insider purchases of PLSE were filed in the last 90 days, totaling $100K.
How many insiders are selling PLSE stock?
No insider sales of PLSE were filed in the last 90 days. 18 sales are on record for this company.
Where can I see PLSE SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects PLSE Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Liane Rae Teplitsky view on EDGAR
- - Liane Rae Teplitsky view on EDGAR
- - Jon Skinner view on EDGAR
- - Mahkam Zanganeh view on EDGAR
- - Den Broek Richard van view on EDGAR
- - Robert W. Duggan view on EDGAR
- - Manmeet Singh Soni view on EDGAR
- - Maria Sainz view on EDGAR
- - Robert W. Duggan view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where PLSE's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow PLSE with a 7-day demo
- PLSE on your watchlist
- Every PLSE Form 4 filing on record
- Up to 3 months of PLSE price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
